Newburyport, MA, United States of America

Emma Krause

This inventor holds 1 USPTO granted patent. Top assignee: Pathai, Inc.. Active years: 2026.


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Emma Krause: Innovator in Predictive Healthcare Technology

Introduction

Emma Krause is a notable inventor based in Newburyport, MA (US). She has made significant contributions to the field of healthcare technology, particularly in the area of predictive analytics for disease severity.

Latest Patents

Emma holds a patent for "Systems and methods for predicting disease severity in ulcerative colitis." This innovative patent describes a method, system, or non-transitory computer-readable storage medium for training models to predict ulcerative colitis (UC) severity based on human-interpretable image features extracted from whole-slide images. The process involves accessing a plurality of annotated whole-slide images associated with UC patients, extracting human-interpretable image features, training a statistical model, and storing the trained model on a storage device. She has 1 patent to her name.

Career Highlights

Emma is currently employed at Pathai, Inc., where she applies her expertise in predictive modeling and healthcare technology. Her work focuses on enhancing the understanding and treatment of ulcerative colitis through advanced imaging techniques.

Collaborations

Emma collaborates with talented professionals in her field, including Fedaa Najdawi and Kathleen Sucipto. These partnerships contribute to the innovative environment at Pathai, Inc., fostering advancements in healthcare technology.

Conclusion

Emma Krause is a pioneering inventor whose work in predictive healthcare technology is making a significant impact on the understanding of ulcerative colitis. Her contributions are paving the way for improved patient outcomes and innovative solutions in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…